Enovis CORP

Enovis Corporation is a medical technology company that develops, manufactures, and distributes clinically differentiated solutions designed to improve patient outcomes and transform workflows. The company provides high-quality medical devices across a broad range of products used for reconstructive surgery, rehabilitation, pain management, and physical therapy. Enovis's products address the entire patient care continuum, from injury prevention to rehabilitation following surgery, injury, or degenerative disease, helping individuals regain or maintain natural motion. The company utilizes its Enovis Growth Excellence (EGX) business system, which is a set of tools, processes, and culture, to continuously improve patient outcomes and drive growth. During the year ended December 31, 2025, Enovis completed four acquisitions within its Reconstructive segment and three acquisitions within its Prevention & Recovery segment. These small acquisitions added complementary prevention & recovery product offerings, expanded distribution partners for the company's surgical implant products in Europe, and introduced a complementary surgical product technology. EGX is integral to Enovis's operations, incorporating its values and driving behaviors through comprehensive tools and repeatable processes used for continuous improvement and value creation.